These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
04-2833935
|
|
(State or other jurisdiction
of incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
|
|
|
|
125 North Drive, Westborough, MA
|
01581-3335
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Registrant’s telephone number, including area code:
|
(508) 870-5959
|
|
Securities registered pursuant to Section 12(b) of the Act:
|
Common Stock, par value $.01 per share
|
|
|
(Title of Class)
|
|
Name of each exchange on which registered
|
NASDAQ Global Market
|
|
Securities registered pursuant to Section 12(g) of the Act:
|
None
|
|
Large Accelerated Filer
|
¨
|
Accelerated Filer
|
x
|
Non-Accelerated Filer
|
¨
|
Smaller Reporting Company
|
¨
|
|
|
|
|
|
Item 1.
|
Business
|
|
|
|
Percent of Total
Revenues
|
||||
|
Customer
|
|
2014
|
|
2013
|
|
2012
|
|
Military Customers in Total
|
|
45%
|
|
38%
|
|
57%
|
|
Raytheon Company
|
|
26%
|
|
14%
|
|
22%
|
|
Google Inc.
|
|
11%
|
|
*
|
|
*
|
|
DRS RSTA Inc.
|
|
*
|
|
*
|
|
21%
|
|
Ryoden Trading Company
|
|
*
|
|
18%
|
|
12%
|
|
U.S. Government funded research and development contracts
|
|
4%
|
|
10%
|
|
10%
|
|
•
|
Passive Matrix Liquid Crystal Display. These displays are primarily used in calculators, simple watches and wireless handsets because of their relatively low cost and low power consumption. Their relatively low image quality, slow response time and limited viewing angle, however, make them inadequate for many demanding applications.
|
|
•
|
Active Matrix Liquid Crystal Display. These displays are used primarily in wireless handsets, tablets, laptop computers, televisions and projection systems. In contrast to passive matrix LCDs, color active matrix LCDs incorporate three transistors at every pixel location. This arrangement allows each sub-pixel to be turned on and off independently which improves image quality and response time and also provides an improved side-to-side viewing angle of the display.
|
|
•
|
Greater miniaturization;
|
|
•
|
Higher pixel density;
|
|
•
|
Full color capability; and
|
|
•
|
Lower power consumption.
|
|
•
|
Broad Portfolio of Intellectual Property.
We believe that our extensive portfolio of patents, trade secrets and non-patented know-how provides us with a competitive advantage in the wearable computing industry and we have been accumulating, either by internal efforts or through acquisition, a significant patent and know-how portfolio. We own, exclusively license or have the sole right to sublicense more than 250 patents issued and pending worldwide. An important piece of our strategy is to continue to accumulate valuable patented and non-patented technical know-how relating to our micro displays as well as other critical technologies for advanced wearable services.
|
|
•
|
Maintain Our Technological Leadership.
We are a recognized leader in the design, development and manufacture of high resolution micro displays and modules which incorporate our micro displays with backlights, optic and ASICs and we believe our ability to develop components, software and noise cancelling technology and innovative concept system designs enhances our opportunity to grow within our targeted markets. By continuing to invest in research and development, we are able to add to our expertise as a system and components supplier for our OEM customers, and we intend to continue to focus our development efforts on proprietary wearable computing systems.
|
|
•
|
Develop Headset Concept Systems.
The Wearable device market is just beginning and part of our strategy is to develop headset concept systems in order to facilitate for our customers the design-in process of our components into their finished products. We believe our understanding of the issues associated with our customers’ products and our ability to help them optimize their product offering has been an important reason we have previously been successful in developing customer relationships. Our strategy is to licenses our concept systems to companies that wish to offer products for the wearable market and then sell them critical components including display,
|
|
•
|
Strong U.S. Government Program Support.
We perform under research and development contracts with U.S. government agencies, such as the U.S. Night Vision Laboratory and the U.S. Department of Defense. Under these contracts, the U.S. Government funds a portion of our efforts to develop next-generation micro display related technologies. This enables us to supplement our internal research and development budget with additional funding.
|
|
John C.C. Fan, age 71
|
|
Bor-Yeu Tsaur, age 59
|
||||
|
|
|
President, Chief Executive Officer and Chairman
|
|
|
|
Executive Vice President—Display Operations
|
|
|
|
Founded Kopin in 1984
|
|
|
|
Joined Kopin in 1997
|
|
|
|
|
|
|
|
|
|
Richard A. Sneider, age 54
|
|
Michael Presz, age 61
|
||||
|
|
|
Treasurer and Chief Financial Officer
|
|
|
|
Vice President—Government Programs and Special Projects
|
|
|
|
Joined Kopin in 1998
|
|
|
|
Joined Kopin in 1994
|
|
|
|
|
|
|
|
|
|
Hong Choi, age 63
|
|
|
||||
|
|
|
Vice President and Chief Technology Officer
|
|
|
|
|
|
|
|
Joined Kopin in 2000
|
|
|
|
|
|
Item 1A.
|
Risk Factors
|
|
•
|
Lack of control over production capacity and delivery schedules;
|
|
•
|
Limited control over quality assurance, manufacturing yields and production costs;
|
|
•
|
The risks associated with international commerce, including unexpected changes in legal and regulatory requirements, changes in tariffs and trade policies and political and economic instability; and
|
|
•
|
Natural disasters such as earthquakes, tsunami, mudslides, drought, hurricanes and tornadoes.
|
|
•
|
the security capabilities, reliability and availability of cloud-based services;
|
|
•
|
our ability to implement upgrades and other changes to our software without disrupting our service;
|
|
•
|
the level of customization or configuration we offer; and
|
|
•
|
the price, performance and availability of competing products and services.
|
|
•
|
The timing and successful introduction of additional manufacturing capacity;
|
|
•
|
The timing of the initial selection of our Wearable technology and display products as component in our customers' new products;
|
|
•
|
Availability of interface electronics for our display products;
|
|
•
|
Competitive pressures on selling prices of our products;
|
|
•
|
The timing and cancellation of customer orders;
|
|
•
|
Our ability to introduce new products and technologies on a timely basis;
|
|
•
|
Our ability to successfully reduce costs;
|
|
•
|
The cancellation of U.S. government contracts; and
|
|
•
|
Our ability to secure agreements from our major customers for the purchase of our products.
|
|
•
|
The Federal Acquisition Regulation, which comprehensively regulates the formation, administration and performance of federal government contracts;
|
|
•
|
The Truth in Negotiations Act, which requires certification and disclosure of all cost and pricing data in connection with contract negotiations;
|
|
•
|
The Cost Accounting Standards and Cost Principles, which impose accounting requirements that govern our right to reimbursement under certain cost-based federal government contracts; and
|
|
•
|
Laws, regulations and executive orders restricting the use and dissemination of information classified for national security purposes and the export of certain products, services and technical data. We engage in international work falling under the jurisdiction of U.S. export control laws. Failure to comply with these control regimes can lead to severe penalties, both civil and criminal, and can include debarment from contracting with the U.S. government.
|
|
•
|
Termination of contracts;
|
|
•
|
Forfeiture of profits;
|
|
•
|
Cost associated with triggering of price reduction clauses;
|
|
•
|
Suspension of payments;
|
|
Item 1B.
|
Unresolved Staff Comments
|
|
Item 2.
|
Properties
|
|
Item 3.
|
Legal Proceedings
|
|
Item 4.
|
Mine Safety Disclosures
|
|
Item 5.
|
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
|
|
|
High
|
|
Low
|
||||
|
Fiscal Year Ended December 27, 2014
|
|
|
|
||||
|
First Quarter
|
$
|
4.49
|
|
|
$
|
3.56
|
|
|
Second Quarter
|
3.82
|
|
|
2.92
|
|
||
|
Third Quarter
|
4.32
|
|
|
3.03
|
|
||
|
Fourth Quarter
|
3.80
|
|
|
3.10
|
|
||
|
Fiscal Year Ended December 28, 2013
|
|
|
|
||||
|
First Quarter
|
$
|
3.71
|
|
|
$
|
3.17
|
|
|
Second Quarter
|
3.78
|
|
|
3.13
|
|
||
|
Third Quarter
|
4.33
|
|
|
3.30
|
|
||
|
Fourth Quarter
|
4.28
|
|
|
3.43
|
|
||
|
Plan Category
|
Number of securities to be issued upon exercise of outstanding options,
warrants and rights (a)
|
|
Weighted-average exercise price of outstanding options, warrants and rights
|
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column a)
|
|
||||
|
Total equity compensation plans approved by security holders (1)
|
130,500
|
|
|
$
|
3.49
|
|
|
3,008,080
|
|
(2)
|
|
(1)
|
Consists of the 2001 Equity Incentive Plan and the 2010 Equity Incentive Plan.
|
|
(2)
|
Shares available under the 2010 Equity Incentive Plan.
|
|
Period
|
Total
Number
of Shares
Purchased
|
Average
Price Paid
per Share
|
Total
Number of
Shares
Purchased
as Part of
Publicly
Announced
Plans or
Programs
|
Maximum
Approximate
Dollar Value
of Shares that
May Yet Be
Purchased
Under the
Plans or
Programs
|
||||||
|
December 29, 2013 - January 25, 2014,
|
69,721
|
|
$
|
4.28
|
|
69,721
|
|
$
|
21,709,427
|
|
|
January 26, 2014 - February 22, 2014
|
—
|
|
|
—
|
|
$
|
21,709,427
|
|
||
|
February 23, 2013 - March 17, 2014
|
—
|
|
|
—
|
|
$
|
21,709,427
|
|
||
|
Total
|
69,721
|
|
$
|
4.28
|
|
69,721
|
|
|
||
|
Item 6.
|
Selected Financial Data
|
|
|
Fiscal Year Ended
|
||||||||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
|
|
(in thousands, except per share data)
|
||||||||||||||||||
|
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Revenues:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net component revenues
|
$
|
26,957
|
|
|
$
|
20,575
|
|
|
$
|
31,299
|
|
|
$
|
59,509
|
|
|
$
|
54,969
|
|
|
Research and development revenues
|
4,851
|
|
|
2,323
|
|
|
3,343
|
|
|
5,150
|
|
|
3,172
|
|
|||||
|
Total revenues
|
31,808
|
|
|
22,898
|
|
|
34,642
|
|
|
64,659
|
|
|
58,141
|
|
|||||
|
Expenses:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cost of component revenues
|
19,638
|
|
|
20,655
|
|
|
22,042
|
|
|
34,659
|
|
|
35,597
|
|
|||||
|
Research and development—funded programs
|
5,237
|
|
|
1,551
|
|
|
2,178
|
|
|
3,341
|
|
|
2,175
|
|
|||||
|
Research and development—internal
|
15,499
|
|
|
15,983
|
|
|
12,121
|
|
|
13,218
|
|
|
10,972
|
|
|||||
|
Selling, general and administrative
|
19,909
|
|
|
19,125
|
|
|
17,166
|
|
|
15,991
|
|
|
12,322
|
|
|||||
|
Impairment of intangible assets and goodwill
|
—
|
|
|
1,511
|
|
|
1,705
|
|
|
5,000
|
|
|
—
|
|
|||||
|
|
60,283
|
|
|
58,825
|
|
|
55,212
|
|
|
72,209
|
|
|
61,066
|
|
|||||
|
Loss from operations
|
(28,475
|
)
|
|
(35,927
|
)
|
|
(20,570
|
)
|
|
(7,550
|
)
|
|
(2,925
|
)
|
|||||
|
Other income and (expense):
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Interest income
|
966
|
|
|
1,119
|
|
|
1,126
|
|
|
1,291
|
|
|
1,978
|
|
|||||
|
Other income and (expense), net
|
271
|
|
|
235
|
|
|
174
|
|
|
143
|
|
|
(31
|
)
|
|||||
|
Foreign currency transaction gains (losses)
|
92
|
|
|
(387
|
)
|
|
(1,032
|
)
|
|
10
|
|
|
(304
|
)
|
|||||
|
Impairment of investments
|
(1,319
|
)
|
|
(5,000
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Loss on remeasurement of investment in Intoware
|
—
|
|
|
—
|
|
|
(558
|
)
|
|
—
|
|
|
—
|
|
|||||
|
Other-than-temporary impairment of marketable debt securities
|
—
|
|
|
—
|
|
|
—
|
|
|
(151
|
)
|
|
—
|
|
|||||
|
Gain on sales of investments
|
—
|
|
|
1,899
|
|
|
856
|
|
|
369
|
|
|
2,598
|
|
|||||
|
Gain on sales of patents
|
—
|
|
|
—
|
|
|
—
|
|
|
156
|
|
|
770
|
|
|||||
|
|
10
|
|
|
(2,134
|
)
|
|
566
|
|
|
1,818
|
|
|
5,011
|
|
|||||
|
(Loss) income before benefit (provision) for income taxes, equity losses in unconsolidated affiliates and net loss (income) of noncontrolling interest
|
(28,465
|
)
|
|
(38,061
|
)
|
|
(20,004
|
)
|
|
(5,732
|
)
|
|
2,086
|
|
|||||
|
Tax benefit (provision)
|
180
|
|
|
12,933
|
|
|
(1,099
|
)
|
|
—
|
|
|
54
|
|
|||||
|
(Loss) income before equity losses in unconsolidated affiliates and net loss (income) of noncontrolling interest
|
(28,285
|
)
|
|
(25,128
|
)
|
|
(21,103
|
)
|
|
(5,732
|
)
|
|
2,140
|
|
|||||
|
Equity losses in unconsolidated affiliates
|
(386
|
)
|
|
(625
|
)
|
|
(680
|
)
|
|
(297
|
)
|
|
(600
|
)
|
|||||
|
(Loss) income from continuing operations
|
$
|
(28,671
|
)
|
|
$
|
(25,753
|
)
|
|
$
|
(21,783
|
)
|
|
$
|
(6,029
|
)
|
|
$
|
1,540
|
|
|
Income from discontinued operations, net of tax
|
—
|
|
|
20,147
|
|
|
2,789
|
|
|
9,713
|
|
|
7,300
|
|
|||||
|
Net (loss) income
|
(28,671
|
)
|
|
(5,606
|
)
|
|
(18,994
|
)
|
|
3,684
|
|
|
8,840
|
|
|||||
|
Net loss (income) attributable to the noncontrolling interest
|
459
|
|
|
896
|
|
|
632
|
|
|
(605
|
)
|
|
(11
|
)
|
|||||
|
Net (loss) income attributable to the controlling interest
|
$
|
(28,212
|
)
|
|
$
|
(4,710
|
)
|
|
$
|
(18,362
|
)
|
|
$
|
3,079
|
|
|
$
|
8,829
|
|
|
Net (loss) income per share:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
|
Continuing operations
|
$
|
(0.45
|
)
|
|
$
|
(0.40
|
)
|
|
$
|
(0.33
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
0.02
|
|
|
Discontinued operations
|
—
|
|
|
0.32
|
|
|
0.04
|
|
|
0.15
|
|
|
0.12
|
|
|||||
|
Net (loss) income per share:
|
$
|
(0.45
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.29
|
)
|
|
$
|
0.05
|
|
|
$
|
0.14
|
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Continuing operations
|
$
|
(0.45
|
)
|
|
$
|
(0.40
|
)
|
|
$
|
(0.33
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
0.02
|
|
|
Discontinued operations
|
—
|
|
|
0.32
|
|
|
0.04
|
|
|
0.15
|
|
|
0.11
|
|
|||||
|
Net (loss) income per share:
|
$
|
(0.45
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.29
|
)
|
|
$
|
0.05
|
|
|
$
|
0.13
|
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Basic
|
62,639
|
|
|
62,348
|
|
|
63,618
|
|
|
64,406
|
|
|
66,020
|
|
|||||
|
Diluted
|
62,639
|
|
|
62,348
|
|
|
63,618
|
|
|
65,234
|
|
|
66,712
|
|
|||||
|
|
Fiscal Year Ended
|
||||||||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|
2011
|
|
2010
|
||||||||||
|
Balance Sheet Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Cash and equivalents and marketable debt securities
|
$
|
90,859
|
|
|
$
|
112,729
|
|
|
$
|
92,485
|
|
|
$
|
105,419
|
|
|
$
|
110,947
|
|
|
Working capital
|
86,682
|
|
|
108,369
|
|
|
106,791
|
|
|
123,257
|
|
|
132,098
|
|
|||||
|
Total assets
|
122,941
|
|
|
146,132
|
|
|
176,209
|
|
|
193,872
|
|
|
192,096
|
|
|||||
|
Long-term obligations
|
311
|
|
|
329
|
|
|
946
|
|
|
1,296
|
|
|
945
|
|
|||||
|
Total stockholders’ equity
|
109,847
|
|
|
134,563
|
|
|
155,086
|
|
|
170,097
|
|
|
170,625
|
|
|||||
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
Revenues by Category (in millions)
|
2014
|
|
2013
|
||||
|
Military Applications
|
$
|
14.3
|
|
|
$
|
8.6
|
|
|
Consumer Applications
|
2.8
|
|
|
5.3
|
|
||
|
Industrial Applications
|
3.7
|
|
|
2.4
|
|
||
|
Wearable Applications
|
6.2
|
|
|
4.3
|
|
||
|
Research & Development
|
4.8
|
|
|
2.3
|
|
||
|
Total
|
$
|
31.8
|
|
|
$
|
22.9
|
|
|
|
2014
|
|
2013
|
||||
|
Cost of component revenues (in millions)
|
$
|
19.6
|
|
|
$
|
20.7
|
|
|
Cost of component revenues as a % of net component revenues
|
72.9
|
%
|
|
100.4
|
%
|
||
|
(in millions)
|
2014
|
|
2013
|
||||
|
Funded
|
$
|
5.2
|
|
|
$
|
1.5
|
|
|
Internal
|
15.5
|
|
|
16.0
|
|
||
|
Total
|
$
|
20.7
|
|
|
$
|
17.5
|
|
|
|
2014
|
|
2013
|
||||
|
Selling, general and administrative expense (in millions)
|
$
|
19.9
|
|
|
$
|
19.1
|
|
|
Selling, general and administrative expense as a % of revenues
|
62.6
|
%
|
|
82.3
|
%
|
||
|
(in millions)
|
Intangible
Assets
|
||
|
As of December 31, 2011
|
$
|
1.9
|
|
|
Amortization
|
(0.3
|
)
|
|
|
Foreign currency translation
|
0.1
|
|
|
|
As of December 29, 2012
|
$
|
1.7
|
|
|
Amortization
|
(0.4
|
)
|
|
|
Impairment of goodwill
|
(1.2
|
)
|
|
|
Foreign currency translation
|
0.1
|
|
|
|
As of December 28, 2013
|
$
|
0.2
|
|
|
Amortization
|
(0.2
|
)
|
|
|
As of December 27, 2014
|
$
|
—
|
|
|
(in millions)
|
2014
|
|
2013
|
||||
|
Interest income
|
$
|
0.9
|
|
|
$
|
1.1
|
|
|
Other income and expense, net
|
0.3
|
|
|
0.3
|
|
||
|
Foreign currency transaction losses
|
0.1
|
|
|
(0.4
|
)
|
||
|
Subtotal
|
1.3
|
|
|
1.0
|
|
||
|
Gain on sales of investments
|
—
|
|
|
1.9
|
|
||
|
Impairment of investments
|
(1.3
|
)
|
|
(5.0
|
)
|
||
|
Other income and expense
|
$
|
—
|
|
|
$
|
(2.1
|
)
|
|
|
2014
|
|
2013
|
||||
|
Intoware
|
$
|
0.3
|
|
|
$
|
0.5
|
|
|
eMDT
|
0.1
|
|
|
0.3
|
|
||
|
Kowon
|
—
|
|
|
0.1
|
|
||
|
Total
|
$
|
0.4
|
|
|
$
|
0.9
|
|
|
Revenues by Category (in millions)
|
2013
|
|
2012
|
||||
|
Military Applications
|
$
|
8.6
|
|
|
$
|
19.6
|
|
|
Consumer Electronic Applications
|
8.1
|
|
|
8.6
|
|
||
|
Eyewear Applications
|
3.9
|
|
|
3.0
|
|
||
|
Research & Development
|
2.3
|
|
|
3.4
|
|
||
|
Total
|
$
|
22.9
|
|
|
$
|
34.6
|
|
|
|
2013
|
|
2012
|
||||
|
Cost of product revenues (in millions)
|
$
|
20.7
|
|
|
$
|
22.0
|
|
|
Cost of product revenues as a % of revenues
|
100.4
|
%
|
|
70.3
|
%
|
||
|
Research and development expense
|
2013
|
|
2012
|
||||
|
Funded
|
$
|
1.5
|
|
|
$
|
2.2
|
|
|
Internal
|
16.0
|
|
|
12.1
|
|
||
|
Total
|
$
|
17.5
|
|
|
$
|
14.3
|
|
|
|
2013
|
|
2012
|
||||
|
Selling, general and administrative expense (in millions)
|
$
|
19.1
|
|
|
$
|
17.2
|
|
|
Selling, general and administrative expense as a % of revenues
|
82.3
|
%
|
|
49.6
|
%
|
||
|
(in millions)
|
Intangible
Assets
|
|
Assets acquired with acquisition of FDD at Jan. 11, 2011
|
$4.6
|
|
Amortization
|
(0.7)
|
|
Impairment
|
(2.0)
|
|
Foreign currency translation
|
—
|
|
As of December 31, 2011
|
$1.9
|
|
Amortization
|
(0.3)
|
|
Impairment of goodwill
|
—
|
|
Foreign currency translation
|
0.1
|
|
As of December 29, 2012
|
$1.7
|
|
Amortization
|
(0.4)
|
|
Impairment of goodwill
|
(1.2)
|
|
Foreign currency translation
|
0.1
|
|
As of December 28, 2013
|
$0.2
|
|
(in millions)
|
2013
|
|
|
2012
|
|
||
|
Interest income
|
$
|
1.1
|
|
|
$
|
1.1
|
|
|
Other income and expense, net
|
0.3
|
|
|
0.2
|
|
||
|
Foreign currency transaction losses
|
(0.4
|
)
|
|
(1.0
|
)
|
||
|
Other-than-temporary Impairment of marketable debt securities
|
—
|
|
|
—
|
|
||
|
Subtotal
|
1.0
|
|
|
0.3
|
|
||
|
Gain on sales of investments
|
1.9
|
|
|
0.9
|
|
||
|
Gain on sales of patents
|
(5.0
|
)
|
|
(0.6
|
)
|
||
|
Other income and expense
|
$
|
(2.1
|
)
|
|
$
|
0.6
|
|
|
|
2013
|
|
|
2012
|
|
||
|
Kowon
|
$
|
0.1
|
|
|
$
|
0.3
|
|
|
Intoware
|
0.5
|
|
|
0.7
|
|
||
|
eMDT
|
0.3
|
|
|
$
|
—
|
|
|
|
Total
|
$
|
0.9
|
|
|
$
|
1.0
|
|
|
Domestic
|
$
|
77,819,426
|
|
|
Foreign
|
10,771,385
|
|
|
|
Subtotal cash and marketable debt securities
|
88,590,811
|
|
|
|
Cash and marketable debt securities held in other currencies and converted to U.S. dollars
|
2,268,125
|
|
|
|
Total cash and marketable debt securities
|
$
|
90,858,936
|
|
|
Contractual Obligations
|
Total
|
|
Less than 1 year
|
|
1-3 Years
|
|
3-5 years
|
|
More than 5 years
|
||||||||||||
|
Operating Lease Obligations
|
$
|
6,220,853
|
|
|
$
|
1,239,081
|
|
2,214,106
|
|
$
|
2,214,106
|
|
85,333
|
|
$
|
1,914,333
|
|
|
$
|
853,333
|
|
|
Item 7A.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
|
Item 9A.
|
Controls and Procedures
|
|
•
|
Improving the design, operation and monitoring of control activities and procedures associated with user and administrator access to the affected IT systems, including both preventive and detective control activities.
|
|
•
|
Improving the design, operation and monitoring of control activities and procedures associated with program change management of the affected IT systems, including both preventive and detective control activities.
|
|
•
|
Implementing appropriate control activities and procedures associated with monitoring of outsourced service providers related to the affected IT systems.
|
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
|
Item 11.
|
Executive Compensation
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
|
Item 14.
|
Principal Accounting Fees and Services
|
|
Item 15.
|
Exhibits, Financial Statement Schedules
|
|
|
Page
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1
|
|
Amended and Restated Certificate of Incorporation
|
(2
|
)
|
|
|
3.2
|
|
Amendment to Certificate of Incorporation
|
(5
|
)
|
|
|
3.3
|
|
Amendment to Certificate of Incorporation
|
(5
|
)
|
|
|
3.4
|
|
Fourth Amended and Restated By-laws
|
(8
|
)
|
|
|
4
|
|
Specimen Certificate of Common Stock
|
(1
|
)
|
|
|
10.1
|
|
Form of Employee Agreement with Respect to Inventions and Proprietary Information
|
(1
|
)
|
|
|
10.2
|
|
Kopin Corporation 2001 Equity Incentive Plan
|
(7
|
)
|
*
|
|
10.3
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(9
|
)
|
*
|
|
10.4
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(10
|
)
|
*
|
|
10.5
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(11
|
)
|
*
|
|
10.6
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(13
|
)
|
*
|
|
10.7
|
|
Kopin Corporation 2001 Supplemental Equity Incentive Plan
|
(6
|
)
|
*
|
|
10.8
|
|
Form of Key Employee Stock Purchase Agreement
|
(1
|
)
|
*
|
|
10.9
|
|
License Agreement by and between the Company and Massachusetts Institute of Technology dated April 22, 1985, as amended
|
(1
|
)
|
|
|
10.10
|
|
Facility Lease, by and between the Company and Massachusetts Technology Park Corporation, dated October 15, 1993
|
(3
|
)
|
|
|
10.11
|
|
Joint Venture Agreement, by and among the Company, Kowon Technology Co., Ltd., and Korean Investors, dated as of March 3, 1998
|
(4
|
)
|
|
|
10.12
|
|
Eighth Amended and Restated Employment Agreement between the Company and Dr. John C.C. Fan, dated as of December 31, 2014
|
*
|
|
|
|
10.13
|
|
Kopin Corporation Form of Stock Option Agreement under 2001 and 2010 Equity Incentive Plans
|
(12
|
)
|
*
|
|
10.14
|
|
Kopin Corporation 2001 and 2010 Equity Incentive Plan Form of Restricted Stock Purchase Agreement
|
(12
|
)
|
*
|
|
10.15
|
|
Kopin Corporation Fiscal Year 2012 Incentive Bonus Plan
|
*
|
|
|
|
10.16
|
|
Kopin Corporation 2010 Equity Incentive Plan
|
(14
|
)
|
|
|
10.17
|
|
Purchase Agreement, dated January 10, 2013, by and among Kopin Corporation, IQE KC, LLC and IQE plc
|
(15
|
)
|
|
|
21.1
|
|
Subsidiaries of Kopin Corporation
|
|
|
|
|
23.1
|
|
Consent of Independent Registered Public Accounting Firm
|
|
|
|
|
31.1
|
|
Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
31.2
|
|
Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
32.1
|
|
Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
**
|
|
|
|
32.2
|
|
Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
**
|
|
|
|
101
|
|
The following materials from the Company’s Annual Report on Form 10-K for the fiscal year ended December 27, 2014, formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Loss, (iv) Consolidated Statements of Stockholder's Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text
|
|
|
|
|
*
|
|
|
Management contract or compensatory plan required to be filed as an Exhibit to this Annual Report on Form 10-K.
|
|
**
|
|
|
This exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filing.
|
|
(1
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-1, File No. 33-45853, and incorporated herein by reference.
|
|
(2
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-1, File No. 33-57450, and incorporated herein by reference.
|
|
(3
|
)
|
|
Filed as an exhibit to Annual Report on Form 10-K for the fiscal year ended December 31, 1993 and incorporated herein by reference.
|
|
(4
|
)
|
|
Filed as an exhibit to Annual Report on Form 10-Q for the quarterly period ended June 27, 1998 and incorporated herein by reference.
|
|
(5
|
)
|
|
Filed as an exhibit to Quarterly Report on Form 10-Q for the quarterly period ended July 1, 2000 and incorporated herein by reference.
|
|
(6
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8, filed on November 13, 2011 and incorporated herein by reference.
|
|
(7
|
)
|
|
Filed as an appendix to Proxy Statement filed on April 20, 2001 and incorporated herein by reference.
|
|
(8
|
)
|
|
Filed as an exhibit to Current Report on Form 8-K filed on December 12, 2008 and incorporated herein by reference.
|
|
(9
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8 filed on August 16, 2002 and incorporated herein by reference
|
|
(10
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8 filed on March 15, 2004 and incorporated herein by reference.
|
|
(11
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8 filed on May 10, 2004 and incorporated herein by reference.
|
|
(12
|
)
|
|
Filed as an exhibit to Annual Report on Form 10-K for the fiscal year ended December 25, 2004 and incorporated herein by reference.
|
|
(13
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8 filed on April 15, 2008 and incorporated herein by reference.
|
|
(14
|
)
|
|
Filed with the Company's Definitive Proxy Statement on Schedule 14 filed as of April 5, 2013 and incorporated by reference herein.
|
|
(15
|
)
|
|
Filed as an exhibit to Current Report on Form 8-K on January 10, 2013 and incorporated by reference herein.
|
|
|
Page
|
|
Consolidated Balance Sheets at December 27, 2014 and December 28, 2013
|
|
|
|
December 27,
2014 |
|
December 28,
2013 |
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and equivalents
|
$
|
14,635,801
|
|
|
$
|
16,756,666
|
|
|
Marketable debt securities, at fair value
|
76,223,135
|
|
|
95,972,535
|
|
||
|
Accounts receivable, net of allowance of $266,000 and $202,000 in 2014 and 2013, respectively
|
3,758,832
|
|
|
2,388,461
|
|
||
|
Unbilled receivables
|
43,492
|
|
|
—
|
|
||
|
Inventory
|
4,081,886
|
|
|
3,078,055
|
|
||
|
Prepaid taxes
|
378,637
|
|
|
233,642
|
|
||
|
Prepaid expenses and other current assets
|
802,837
|
|
|
1,178,643
|
|
||
|
Total current assets
|
99,924,620
|
|
|
119,608,002
|
|
||
|
Property, plant and equipment, net
|
4,589,421
|
|
|
6,034,963
|
|
||
|
Goodwill
|
976,451
|
|
|
1,016,132
|
|
||
|
Intangible assets, net
|
616,759
|
|
|
1,581,502
|
|
||
|
Other assets
|
1,900,828
|
|
|
3,024,458
|
|
||
|
Notes receivable
|
14,933,335
|
|
|
14,866,666
|
|
||
|
Total assets
|
$
|
122,941,414
|
|
|
$
|
146,131,723
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Accounts payable
|
$
|
5,503,734
|
|
|
$
|
3,868,865
|
|
|
Accrued payroll and expenses
|
1,985,691
|
|
|
1,436,391
|
|
||
|
Accrued warranty
|
716,000
|
|
|
716,000
|
|
||
|
Billings in excess of revenue earned
|
586,471
|
|
|
547,681
|
|
||
|
Other accrued liabilities
|
3,169,028
|
|
|
3,157,394
|
|
||
|
Deferred tax liabilities
|
1,282,000
|
|
|
1,512,771
|
|
||
|
Total current liabilities
|
13,242,924
|
|
|
11,239,102
|
|
||
|
Asset retirement obligations
|
311,187
|
|
|
329,435
|
|
||
|
Commitments and contingencies
|
|
|
|
|
|
||
|
Stockholders’ equity:
|
|
|
|
||||
|
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued
|
—
|
|
|
—
|
|
||
|
Common stock, par value $.01 per share: authorized, 120,000,000 shares; issued 77,731,604 shares in 2014 and 77,567,631 shares in 2013; outstanding 63,077,715 in 2014 and 62,560,946 in 2013, respectively
|
751,832
|
|
|
745,935
|
|
||
|
Additional paid-in capital
|
324,625,694
|
|
|
320,511,458
|
|
||
|
Treasury stock (12,102,258 and 12,032,537 shares in 2014 and 2013, respectively, at cost)
|
(42,741,551
|
)
|
|
(42,442,932
|
)
|
||
|
Accumulated other comprehensive income
|
3,126,239
|
|
|
3,441,997
|
|
||
|
Accumulated deficit
|
(175,915,255
|
)
|
|
(147,703,211
|
)
|
||
|
Total Kopin Corporation stockholders’ equity
|
109,846,959
|
|
|
134,553,247
|
|
||
|
Noncontrolling interest
|
(459,656
|
)
|
|
9,939
|
|
||
|
Total stockholders’ equity
|
109,387,303
|
|
|
134,563,186
|
|
||
|
Total liabilities and stockholders’ equity
|
$
|
122,941,414
|
|
|
$
|
146,131,723
|
|
|
Fiscal year ended
|
2014
|
|
2013
|
|
2012
|
||||||
|
Revenues:
|
|
|
|
|
|
||||||
|
Net component revenues
|
$
|
26,956,741
|
|
|
$
|
20,574,812
|
|
|
$
|
31,298,419
|
|
|
Research and development revenues
|
4,850,724
|
|
|
2,322,897
|
|
|
3,343,441
|
|
|||
|
|
31,807,465
|
|
|
22,897,709
|
|
|
34,641,860
|
|
|||
|
Expenses:
|
|
|
|
|
|
||||||
|
Cost of component revenues
|
19,638,149
|
|
|
20,655,216
|
|
|
22,041,953
|
|
|||
|
Research and development-funded programs
|
5,236,791
|
|
|
1,550,873
|
|
|
2,178,472
|
|
|||
|
Research and development-internal
|
15,499,230
|
|
|
15,983,147
|
|
|
12,121,689
|
|
|||
|
Selling, general and administrative
|
19,908,020
|
|
|
19,124,750
|
|
|
17,165,870
|
|
|||
|
Impairment of intangible assets and goodwill
|
—
|
|
|
1,511,414
|
|
|
1,704,770
|
|
|||
|
|
60,282,190
|
|
|
58,825,400
|
|
|
55,212,754
|
|
|||
|
Loss from operations
|
(28,474,725
|
)
|
|
(35,927,691
|
)
|
|
(20,570,894
|
)
|
|||
|
Other income and expense:
|
|
|
|
|
|
||||||
|
Interest income
|
966,403
|
|
|
1,118,617
|
|
|
1,126,344
|
|
|||
|
Other income, net
|
271,537
|
|
|
235,917
|
|
|
173,829
|
|
|||
|
Foreign currency transaction gains (losses)
|
91,725
|
|
|
(387,351
|
)
|
|
(1,032,588
|
)
|
|||
|
Gain on sales of investments
|
—
|
|
|
1,899,291
|
|
|
856,170
|
|
|||
|
Loss on investment in Intoware
|
—
|
|
|
—
|
|
|
(557,594
|
)
|
|||
|
Impairment of equity and cost investments
|
(1,319,287
|
)
|
|
(5,000,442
|
)
|
|
—
|
|
|||
|
|
10,378
|
|
|
(2,133,968
|
)
|
|
566,161
|
|
|||
|
Loss from continuing operations before benefit (provision) for income taxes, and equity losses in unconsolidated affiliates and net loss of noncontrolling interest
|
(28,464,347
|
)
|
|
(38,061,659
|
)
|
|
(20,004,733
|
)
|
|||
|
Tax benefit (provision)
|
180,000
|
|
|
12,933,209
|
|
|
(1,099,000
|
)
|
|||
|
Loss before equity losses in unconsolidated affiliates and net loss of noncontrolling interest
|
(28,284,347
|
)
|
|
(25,128,450
|
)
|
|
(21,103,733
|
)
|
|||
|
Equity losses in unconsolidated affiliates
|
(386,442
|
)
|
|
(625,098
|
)
|
|
(679,587
|
)
|
|||
|
Loss from continuing operations
|
(28,670,789
|
)
|
|
(25,753,548
|
)
|
|
(21,783,320
|
)
|
|||
|
Income from discontinued operations, net of tax
|
—
|
|
|
20,147,532
|
|
|
2,789,048
|
|
|||
|
Net loss
|
$
|
(28,670,789
|
)
|
|
$
|
(5,606,016
|
)
|
|
$
|
(18,994,272
|
)
|
|
Net loss attributable to the noncontrolling interest
|
458,745
|
|
|
896,400
|
|
|
632,342
|
|
|||
|
Net loss attributable to the controlling interest
|
$
|
(28,212,044
|
)
|
|
$
|
(4,709,616
|
)
|
|
$
|
(18,361,930
|
)
|
|
Net (loss) income per share:
|
|
|
|
|
|
||||||
|
Basic:
|
|
|
|
|
|
||||||
|
Continuing operations
|
$
|
(0.45
|
)
|
|
$
|
(0.40
|
)
|
|
$
|
(0.33
|
)
|
|
Discontinued operations
|
—
|
|
|
0.32
|
|
|
0.04
|
|
|||
|
Net loss per share
|
$
|
(0.45
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.29
|
)
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|||
|
Continuing operations
|
$
|
(0.45
|
)
|
|
$
|
(0.40
|
)
|
|
$
|
(0.33
|
)
|
|
Discontinued operations
|
—
|
|
|
0.32
|
|
|
0.04
|
|
|||
|
Net loss per share
|
$
|
(0.45
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.29
|
)
|
|
Weighted average number of common shares outstanding:
|
|
|
|
|
|
||||||
|
Basic
|
62,638,675
|
|
|
62,347,852
|
|
|
63,617,680
|
|
|||
|
Diluted
|
62,638,675
|
|
|
62,347,852
|
|
|
63,617,680
|
|
|||
|
Fiscal years ended
|
2014
|
|
2013
|
|
2012
|
||||||
|
Net loss
|
$
|
(28,670,789
|
)
|
|
$
|
(5,606,016
|
)
|
|
$
|
(18,994,272
|
)
|
|
Other comprehensive (loss) income:
|
|
|
|
|
|
||||||
|
Foreign currency translation adjustments
|
(1,102,859
|
)
|
|
231,321
|
|
|
2,687,344
|
|
|||
|
Unrealized holding gain (loss) on marketable securities
|
681,346
|
|
|
(116,134
|
)
|
|
730,967
|
|
|||
|
Reclassifications of loss in net loss
|
(6,477
|
)
|
|
(1,936,121
|
)
|
|
(586,433
|
)
|
|||
|
Other comprehensive (loss) income
|
$
|
(427,990
|
)
|
|
$
|
(1,820,934
|
)
|
|
$
|
2,831,878
|
|
|
Comprehensive loss
|
(29,098,779
|
)
|
|
(7,426,950
|
)
|
|
(16,162,394
|
)
|
|||
|
Comprehensive gain attributable to the noncontrolling interest
|
570,977
|
|
|
871,867
|
|
|
167,232
|
|
|||
|
Comprehensive loss attributable to the controlling interest
|
$
|
(28,527,802
|
)
|
|
$
|
(6,555,083
|
)
|
|
$
|
(15,995,162
|
)
|
|
|
Common Stock
|
|
Additional
Paid-in
Capital
|
|
Treasury
Stock
|
|
Accumulated
Other
Comprehensive
Income
|
|
Accumulated
Deficit
|
|
Total Kopin
Corporation
Stockholders’
Equity
|
|
Noncontrolling
interest
|
|
Total
Stockholders’
Equity
|
|||||||||||||||||||
|
|
Shares
|
|
Amount
|
|
||||||||||||||||||||||||||||||
|
Balance December 31, 2011
|
73,226,258
|
|
|
$
|
732,263
|
|
|
$
|
315,710,160
|
|
|
$
|
(30,995,449
|
)
|
|
$
|
4,146,024
|
|
|
$
|
(124,631,666
|
)
|
|
$
|
164,961,332
|
|
|
$
|
5,135,423
|
|
|
$
|
170,096,756
|
|
|
Vesting of restricted stock
|
671,568
|
|
|
6,716
|
|
|
(6,716
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
Stock based compensation expense
|
—
|
|
|
—
|
|
|
3,851,672
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,851,672
|
|
|
—
|
|
|
3,851,672
|
|
||||||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,366,768
|
|
|
—
|
|
|
2,366,768
|
|
|
465,110
|
|
|
2,831,878
|
|
||||||||
|
Acquisition of Ikanos equity interest
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,384,039
|
|
|
1,384,039
|
|
||||||||
|
Restricted stock for tax withholding obligations
|
(201,182
|
)
|
|
(2,013
|
)
|
|
(626,621
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(628,634
|
)
|
|
—
|
|
|
(628,634
|
)
|
||||||||
|
Treasury stock purchase
|
—
|
|
|
—
|
|
|
—
|
|
|
(3,455,529
|
)
|
|
—
|
|
|
—
|
|
|
(3,455,529
|
)
|
|
—
|
|
|
(3,455,529
|
)
|
||||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(18,361,930
|
)
|
|
(18,361,930
|
)
|
|
(632,342
|
)
|
|
(18,994,272
|
)
|
||||||||
|
Balance December 29, 2012
|
73,696,644
|
|
|
$
|
736,966
|
|
|
$
|
318,928,495
|
|
|
$
|
(34,450,978
|
)
|
|
$
|
6,512,792
|
|
|
$
|
(142,993,596
|
)
|
|
$
|
148,733,679
|
|
|
$
|
6,352,230
|
|
|
$
|
155,085,910
|
|
|
Vesting of restricted stock
|
1,216,900
|
|
|
12,169
|
|
|
(12,169
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
Stock based compensation expense
|
—
|
|
|
—
|
|
|
3,804,408
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,804,408
|
|
|
—
|
|
|
3,804,408
|
|
||||||||
|
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,845,466
|
)
|
|
—
|
|
|
(1,845,466
|
)
|
|
24,532
|
|
|
(1,820,934
|
)
|
||||||||
|
Sale of III-V product line
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,580,629
|
)
|
|
—
|
|
|
(1,580,629
|
)
|
|
(2,673,051
|
)
|
|
(4,253,680
|
)
|
||||||||
|
Acquisition of eMDT
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
200,198
|
|
|
200,198
|
|
|||||||||
|
Acquisition of noncontrolling interest in Kowon
|
—
|
|
|
—
|
|
|
(1,020,130
|
)
|
|
—
|
|
|
355,300
|
|
|
—
|
|
|
(664,830
|
)
|
|
(2,997,570
|
)
|
|
(3,662,400
|
)
|
||||||||
|
Restricted stock for tax withholding obligations
|
(320,061
|
)
|
|
(3,200
|
)
|
|
(1,189,146
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1,192,346
|
)
|
|
—
|
|
|
(1,192,346
|
)
|
||||||||
|
Treasury stock purchase
|
—
|
|
|
—
|
|
|
—
|
|
|
(7,991,954
|
)
|
|
—
|
|
|
—
|
|
|
(7,991,954
|
)
|
|
—
|
|
|
(7,991,954
|
)
|
||||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,709,616
|
)
|
|
(4,709,616
|
)
|
|
(896,400
|
)
|
|
(5,606,016
|
)
|
||||||||
|
Balance, December 28, 2013
|
74,593,483
|
|
|
$
|
745,935
|
|
|
$
|
320,511,458
|
|
|
$
|
(42,442,932
|
)
|
|
$
|
3,441,997
|
|
|
$
|
(147,703,211
|
)
|
|
$
|
134,553,247
|
|
|
$
|
9,939
|
|
|
$
|
134,563,186
|
|
|
Exercise of stock options
|
36,750
|
|
|
368
|
|
|
137,445
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
137,812
|
|
|
—
|
|
|
137,812
|
|
||||||||
|
Vesting of restricted stock
|
843,116
|
|
|
8,431
|
|
|
(8,431
|
)
|
|
—
|
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||||
|
Stock based compensation expense
|
—
|
|
|
—
|
|
|
5,059,572
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
5,059,572
|
|
|
—
|
|
|
5,059,572
|
|
||||||||
|
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(315,758
|
)
|
|
—
|
|
|
(315,758
|
)
|
|
(112,232
|
)
|
|
(427,990
|
)
|
||||||||
|
Acquisition of eMDT
|
—
|
|
|
—
|
|
|
(101,382
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(101,382
|
)
|
|
101,382
|
|
|
—
|
|
||||||||
|
Restricted stock for tax withholding obligations
|
(290,142
|
)
|
|
(2,901
|
)
|
|
(972,968
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(975,869
|
)
|
|
—
|
|
|
(975,869
|
)
|
||||||||
|
Treasury stock purchase
|
—
|
|
|
—
|
|
|
—
|
|
|
(298,619
|
)
|
|
—
|
|
|
—
|
|
|
(298,619
|
)
|
|
—
|
|
|
(298,619
|
)
|
||||||||
|
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(28,212,044
|
)
|
|
(28,212,044
|
)
|
|
(458,745
|
)
|
|
(28,670,789
|
)
|
||||||||
|
Balance, December 27, 2014
|
75,183,207
|
|
|
$
|
751,833
|
|
|
$
|
324,625,694
|
|
|
$
|
(42,741,551
|
)
|
|
$
|
3,126,239
|
|
|
$
|
(175,915,255
|
)
|
|
$
|
109,846,959
|
|
|
$
|
(459,656
|
)
|
|
$
|
109,387,303
|
|
|
Fiscal year ended
|
2014
|
|
2013
|
|
2012
|
||||||
|
Cash flows from operating activities:
|
|
|
|
|
|
||||||
|
Net loss
|
$
|
(28,670,789
|
)
|
|
$
|
(5,606,016
|
)
|
|
$
|
(18,994,272
|
)
|
|
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
|
|
|
|
|
|
||||||
|
Depreciation and amortization
|
3,002,014
|
|
|
3,646,725
|
|
|
9,111,943
|
|
|||
|
Accretion (amortization) of premium or discount on marketable debt securities
|
53,437
|
|
|
360,403
|
|
|
(287,439
|
)
|
|||
|
Stock-based compensation
|
4,827,772
|
|
|
4,203,408
|
|
|
4,486,990
|
|
|||
|
Net gain on investment transactions
|
—
|
|
|
(1,899,291
|
)
|
|
(856,170
|
)
|
|||
|
Losses in unconsolidated affiliates
|
102,305
|
|
|
625,098
|
|
|
679,587
|
|
|||
|
Impairment of intangible assets and goodwill
|
—
|
|
|
1,511,414
|
|
|
1,704,770
|
|
|||
|
Gain on sale of III-V product line
|
—
|
|
|
(33,452,176
|
)
|
|
—
|
|
|||
|
Gain on sale of equipment
|
283,333
|
|
|
—
|
|
|
—
|
|
|||
|
Deferred income taxes
|
(230,725
|
)
|
|
252,687
|
|
|
2,162,246
|
|
|||
|
Foreign currency (gains) losses
|
(96,819
|
)
|
|
341,590
|
|
|
1,236,194
|
|
|||
|
Loss on remeasurement of investment in Intoware
|
—
|
|
|
—
|
|
|
557,594
|
|
|||
|
Impairment of investments
|
1,319,287
|
|
|
5,000,442
|
|
|
—
|
|
|||
|
Change in allowance for bad debt
|
63,340
|
|
|
(107,694
|
)
|
|
(129,370
|
)
|
|||
|
Other non-cash items
|
489,332
|
|
|
733,428
|
|
|
402,938
|
|
|||
|
Changes in assets and liabilities:
|
|
|
|
|
|
||||||
|
Accounts receivable
|
(1,286,407
|
)
|
|
4,853,073
|
|
|
4,363,447
|
|
|||
|
Inventory
|
(1,520,824
|
)
|
|
2,262,547
|
|
|
3,466,568
|
|
|||
|
Prepaid expenses and other current assets
|
191,367
|
|
|
(179,858
|
)
|
|
126,580
|
|
|||
|
Accounts payable and accrued expenses
|
1,829,591
|
|
|
(773,471
|
)
|
|
(2,996,339
|
)
|
|||
|
Billings in excess of revenue earned
|
38,790
|
|
|
(672,714
|
)
|
|
(1,247,066
|
)
|
|||
|
Net cash (used in) provided by operating activities
|
(19,604,996
|
)
|
|
(18,900,405
|
)
|
|
3,788,201
|
|
|||
|
Cash flows from investing activities:
|
|
|
|
|
|
||||||
|
Proceeds from sale of marketable debt securities
|
39,801,276
|
|
|
17,130,488
|
|
|
37,305,871
|
|
|||
|
Purchase of marketable debt securities
|
(19,867,896
|
)
|
|
(49,329,891
|
)
|
|
(39,853,837
|
)
|
|||
|
Proceeds from sale of III-V product line
|
—
|
|
|
55,188,020
|
|
|
—
|
|
|||
|
Cash included in current assets held for sale
|
—
|
|
|
—
|
|
|
(2,388,812
|
)
|
|||
|
Cash paid to acquire Intoware and FDD, net of cash acquired
|
—
|
|
|
—
|
|
|
188,223
|
|
|||
|
Cash paid to acquire eMDT, net of cash acquired
|
—
|
|
|
211,484
|
|
|
—
|
|
|||
|
Purchases of cost based investment
|
—
|
|
|
(3,583,611
|
)
|
|
(2,249,784
|
)
|
|||
|
Proceeds from sale of investments
|
—
|
|
|
2,597,289
|
|
|
856,170
|
|
|||
|
Other assets
|
(38,134
|
)
|
|
(10,552
|
)
|
|
43,564
|
|
|||
|
Proceeds from sale of equipment
|
250,000
|
|
|
—
|
|
|
—
|
|
|||
|
Capital expenditures
|
(1,489,986
|
)
|
|
(741,543
|
)
|
|
(9,831,967
|
)
|
|||
|
Net cash provided by (used in) investing activities
|
18,655,260
|
|
|
21,461,684
|
|
|
(15,930,572
|
)
|
|||
|
Cash flows from financing activities:
|
|
|
|
|
|
||||||
|
Treasury stock purchases
|
(298,619
|
)
|
|
(7,991,954
|
)
|
|
(3,455,529
|
)
|
|||
|
Purchase of noncontrolling interest in Kowon
|
—
|
|
|
(3,662,400
|
)
|
|
—
|
|
|||
|
Proceeds from exercise of stock options
|
137,813
|
|
|
—
|
|
|
—
|
|
|||
|
Settlements of restricted stock for tax withholding obligations
|
(975,869
|
)
|
|
(1,192,346
|
)
|
|
(628,634
|
)
|
|||
|
Net cash used in financing activities
|
(1,136,675
|
)
|
|
(12,846,700
|
)
|
|
(4,084,163
|
)
|
|||
|
Effect of exchange rate changes on cash
|
(34,454
|
)
|
|
(93,300
|
)
|
|
266,758
|
|
|||
|
Net decrease in cash and equivalents
|
(2,120,865
|
)
|
|
(10,378,721
|
)
|
|
(15,959,776
|
)
|
|||
|
Cash and equivalents:
|
|
|
|
|
|
||||||
|
Beginning of year
|
16,756,666
|
|
|
27,135,387
|
|
|
43,095,163
|
|
|||
|
End of year
|
$
|
14,635,801
|
|
|
$
|
16,756,666
|
|
|
$
|
27,135,387
|
|
|
Supplemental disclosure of cash flow information:
|
|
|
|
|
|
||||||
|
Income taxes paid
|
$
|
(18,000
|
)
|
|
$
|
95,000
|
|
|
$
|
75,000
|
|
|
Supplemental schedule of noncash investing activities:
|
|
|
|
|
|
||||||
|
Construction in progress included in accrued expenses
|
$
|
373,000
|
|
|
$
|
105,000
|
|
|
$
|
360,000
|
|
|
Non-cash proceeds from sale of III-V product line
|
$
|
—
|
|
|
$
|
14,866,000
|
|
|
$
|
—
|
|
|
|
2014
|
|
2013
|
||||
|
Raw materials
|
$
|
2,057,202
|
|
|
$
|
1,441,569
|
|
|
Work-in-process
|
1,551,799
|
|
|
1,003,540
|
|
||
|
Finished goods
|
472,885
|
|
|
632,946
|
|
||
|
|
$
|
4,081,886
|
|
|
$
|
3,078,055
|
|
|
|
2014
|
|
2013
|
||||
|
Beginning balance
|
$
|
329,435
|
|
|
$
|
322,477
|
|
|
Additions
|
—
|
|
|
—
|
|
||
|
Charges
|
—
|
|
|
—
|
|
||
|
Accretion and exchange rate change
|
(18,248
|
)
|
|
6,958
|
|
||
|
Ending balance
|
$
|
311,187
|
|
|
$
|
329,435
|
|
|
|
2014
|
|
2013
|
|
2012
|
|||
|
Weighted-average common shares outstanding—basic
|
62,638,675
|
|
|
62,347,852
|
|
|
63,617,680
|
|
|
Stock options and nonvested restricted common stock
|
—
|
|
|
—
|
|
|
—
|
|
|
Weighted-average common shares outstanding—diluted
|
62,638,675
|
|
|
62,347,852
|
|
|
63,617,680
|
|
|
|
2014
|
|
2013
|
|
2012
|
|||
|
Nonvested restricted common stock
|
2,551,631
|
|
|
3,024,148
|
|
|
2,283,048
|
|
|
Stock options
|
130,500
|
|
|
558,850
|
|
|
983,680
|
|
|
Total
|
2,682,131
|
|
|
3,582,998
|
|
|
3,266,728
|
|
|
|
Cumulative
Translation
Adjustment
|
|
Unrealized Holding
Gain (Loss) on
Marketable
Securities
|
|
Accumulated Other
Comprehensive
Income
|
||||||
|
Balance as of December 31, 2011
|
$
|
1,319,870
|
|
|
$
|
2,826,154
|
|
|
$
|
4,146,024
|
|
|
Changes during year
|
2,222,234
|
|
|
144,534
|
|
|
2,366,768
|
|
|||
|
Balance as of December 29, 2012
|
3,542,104
|
|
|
2,970,688
|
|
|
6,512,792
|
|
|||
|
Changes during year
|
(1,017,403
|
)
|
|
(2,053,392
|
)
|
|
(3,070,795
|
)
|
|||
|
Balance as of December 28, 2013
|
2,524,701
|
|
|
917,296
|
|
|
3,441,997
|
|
|||
|
Changes during year
|
(990,626
|
)
|
|
674,868
|
|
|
(315,758
|
)
|
|||
|
Balance as of December 27, 2014
|
$
|
1,534,075
|
|
|
$
|
1,592,164
|
|
|
$
|
3,126,239
|
|
|
|
|
||||||
|
|
December 28, 2013
|
|
December 29, 2012
|
||||
|
Net product and research and development revenues
|
$
|
2.3
|
|
|
$
|
58.8
|
|
|
(Loss) gain from discontinued operations before income taxes
|
(0.2
|
)
|
|
4.5
|
|
||
|
(Provision) benefit for income taxes on discontinued operations
|
—
|
|
|
(1.7
|
)
|
||
|
Discontinued operations, net of tax
|
(0.2
|
)
|
|
2.8
|
|
||
|
Gain on sale, net of $13.1 million of tax
|
20.4
|
|
|
—
|
|
||
|
Income from discontinued operations, net of tax
|
$
|
20.2
|
|
|
$
|
2.8
|
|
|
|
Useful Life
|
|
2014
|
|
2013
|
||||
|
Land
|
|
|
$
|
877,485
|
|
|
$
|
915,595
|
|
|
Buildings
|
10 years
|
|
2,298,367
|
|
|
2,398,188
|
|
||
|
Equipment
|
3-5 years
|
|
19,696,919
|
|
|
20,993,220
|
|
||
|
Leasehold improvements
|
Life of the lease
|
|
3,652,395
|
|
|
3,441,553
|
|
||
|
Furniture and fixtures
|
3 years
|
|
886,985
|
|
|
910,270
|
|
||
|
Equipment under construction
|
|
|
657,142
|
|
|
623,503
|
|
||
|
|
|
|
28,069,293
|
|
|
29,282,329
|
|
||
|
Accumulated depreciation and amortization
|
|
|
(23,479,872
|
)
|
|
(23,247,366
|
)
|
||
|
Net property, plant and equipment
|
|
|
$
|
4,589,421
|
|
|
$
|
6,034,963
|
|
|
|
2014
|
|
2013
|
||||
|
Marketable Equity Securities
|
|
|
|
||||
|
Vuzix Corporation
|
$
|
1,500,777
|
|
|
$
|
1,433,102
|
|
|
GCS Holdings
|
180,347
|
|
|
—
|
|
||
|
Non-Marketable Securities—Equity Method Investments
|
|
|
|
||||
|
KoBrite
|
—
|
|
|
1,421,592
|
|
||
|
Other
|
219,704
|
|
|
169,764
|
|
||
|
Total Other Assets
|
$
|
1,900,828
|
|
|
$
|
3,024,458
|
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
KoBrite
|
$
|
(102,305
|
)
|
|
$
|
(406,811
|
)
|
|
$
|
(573,265
|
)
|
|
Intoware
|
—
|
|
|
—
|
|
|
(106,322
|
)
|
|||
|
Ask Ziggy
|
$
|
(284,137
|
)
|
|
$
|
(218,287
|
)
|
|
$
|
—
|
|
|
Total
|
$
|
(386,442
|
)
|
|
$
|
(625,098
|
)
|
|
$
|
(679,587
|
)
|
|
|
2013
|
|
2012
|
||||
|
Current assets
|
$
|
7,769,000
|
|
|
$
|
9,581,000
|
|
|
Noncurrent assets
|
10,663,000
|
|
|
12,701,000
|
|
||
|
Current liabilities
|
1,207,000
|
|
|
1,215,000
|
|
||
|
Revenues
|
5,085,000
|
|
|
6,010,000
|
|
||
|
Margin loss
|
(2,501,000
|
)
|
|
(2,732,000
|
)
|
||
|
Loss from operations
|
(6,114,000
|
)
|
|
(4,938,000
|
)
|
||
|
Net loss
|
(5,526,000
|
)
|
|
(5,308,000
|
)
|
||
|
|
Fiscal Year Ended
|
||||||
|
|
December 27, 2014
|
|
December 28, 2013
|
||||
|
Beginning Balance
|
$
|
1,016,132
|
|
|
$
|
684,789
|
|
|
Acquisition of Intoware
|
—
|
|
|
395,713
|
|
||
|
Adjustments
|
(39,681
|
)
|
|
(64,370
|
)
|
||
|
Ending Balance
|
$
|
976,451
|
|
|
$
|
1,016,132
|
|
|
|
Years
|
|
Customer relationships
|
7
|
|
Developed technology
|
7
|
|
Trademark portfolio
|
7
|
|
|
|
|
Fair Value Measurement at December 27, 2014 Using:
|
||||||||||||
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Money Markets and Cash Equivalents
|
$
|
14,635,802
|
|
|
$
|
14,635,802
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
U.S. Government Securities
|
57,697,142
|
|
|
21,218,340
|
|
|
36,478,802
|
|
|
—
|
|
||||
|
Corporate Debt
|
5,970,983
|
|
|
—
|
|
|
5,970,983
|
|
|
—
|
|
||||
|
Certificates of Deposit
|
12,555,010
|
|
|
—
|
|
|
12,555,010
|
|
|
—
|
|
||||
|
Vuzix Corporation
|
1,500,777
|
|
|
1,500,777
|
|
|
—
|
|
|
—
|
|
||||
|
GCS Holdings
|
180,347
|
|
|
180,347
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
92,540,061
|
|
|
$
|
37,535,266
|
|
|
$
|
55,004,795
|
|
|
$
|
—
|
|
|
|
|
|
Fair Value Measurement at December 28, 2013 Using:
|
||||||||||||
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Level 3
|
||||||||
|
Money Markets and Cash Equivalents
|
$
|
16,756,666
|
|
|
$
|
16,756,666
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
U.S. Government Securities
|
68,284,392
|
|
|
16,542,003
|
|
|
51,742,389
|
|
|
—
|
|
||||
|
Corporate Debt
|
12,984,331
|
|
|
—
|
|
|
12,984,331
|
|
|
—
|
|
||||
|
Certificates of Deposit
|
14,703,812
|
|
|
—
|
|
|
14,703,812
|
|
|
—
|
|
||||
|
Vuzix Corporation
|
1,433,102
|
|
|
1,433,102
|
|
|
—
|
|
|
—
|
|
||||
|
|
$
|
114,162,303
|
|
|
$
|
34,731,771
|
|
|
$
|
79,430,532
|
|
|
$
|
—
|
|
|
|
Amortized Cost
|
|
Unrealized Gains
|
|
Unrealized Losses
|
|
Fair Value
|
||||||||||||||||||||||||
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
|
2014
|
|
2013
|
||||||||||||||||
|
U.S. government and agency backed securities
|
$
|
57,897,914
|
|
|
$
|
68,970,505
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(200,772
|
)
|
|
$
|
(686,113
|
)
|
|
$
|
57,697,142
|
|
|
$
|
68,284,392
|
|
|
Corporate debt and certificates of deposits
|
18,564,823
|
|
|
27,767,513
|
|
|
—
|
|
|
—
|
|
|
(38,830
|
)
|
|
(79,370
|
)
|
|
18,525,993
|
|
|
27,688,143
|
|
||||||||
|
Total
|
$
|
76,462,737
|
|
|
$
|
96,738,018
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(239,602
|
)
|
|
$
|
(765,483
|
)
|
|
$
|
76,223,135
|
|
|
$
|
95,972,535
|
|
|
|
Less than
One year
|
|
One to
Five years
|
|
Greater than
Five years
|
|
Total
|
||||||||
|
U.S. government and agency backed securities
|
$
|
14,618,790
|
|
|
$
|
35,548,345
|
|
|
$
|
7,530,007
|
|
|
$
|
57,697,142
|
|
|
Corporate debt and certificates of deposits
|
15,883,913
|
|
|
1,680,830
|
|
|
961,250
|
|
|
18,525,993
|
|
||||
|
Total
|
$
|
30,502,703
|
|
|
$
|
37,229,175
|
|
|
$
|
8,491,257
|
|
|
$
|
76,223,135
|
|
|
|
2014
|
|||||
|
|
Shares
|
|
Weighted
Average
Exercise
Price
|
|||
|
Balance, beginning of year
|
558,850
|
|
|
$
|
5.09
|
|
|
Options forfeited/canceled
|
(391,600
|
)
|
|
5.75
|
|
|
|
Options exercised
|
(36,750
|
)
|
|
3.75
|
|
|
|
Balance, end of year
|
130,500
|
|
|
$
|
3.49
|
|
|
Exercisable, end of year
|
130,500
|
|
|
|
||
|
|
Shares
|
|
Weighted
Average
Grant
Fair Value
|
|||
|
Balance, December 28, 2013
|
2,974,148
|
|
|
$
|
4.25
|
|
|
Granted
|
523,000
|
|
|
4.01
|
|
|
|
Forfeited
|
(102,400
|
)
|
|
3.33
|
|
|
|
Vested
|
(843,117
|
)
|
|
3.73
|
|
|
|
Balance, December 27, 2014
|
2,551,631
|
|
|
$
|
4.41
|
|
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Cost of component revenues
|
$
|
766,221
|
|
|
$
|
414,842
|
|
|
$
|
513,789
|
|
|
Research and development
|
965,945
|
|
|
423,548
|
|
|
366,443
|
|
|||
|
Selling, general and administrative
|
3,095,606
|
|
|
3,365,018
|
|
|
3,606,758
|
|
|||
|
Total
|
$
|
4,827,772
|
|
|
$
|
4,203,408
|
|
|
$
|
4,486,990
|
|
|
|
Percent of Gross
Accounts Receivable
|
||
|
Customer
|
2014
|
|
2013
|
|
Company A
|
1
|
|
22
|
|
Company B
|
5
|
|
12
|
|
Company C
|
9
|
|
12
|
|
Company D
|
32
|
|
*
|
|
Company E
|
14
|
|
*
|
|
Company F
|
8
|
|
*
|
|
|
Sales as a Percent
of Total Revenue
|
||||
|
|
Fiscal Year
|
||||
|
Customer
|
2014
|
|
2013
|
|
2012
|
|
Military Customers in Total
|
45
|
|
38
|
|
57
|
|
Company A
|
*
|
|
18
|
|
12
|
|
Company C
|
11
|
|
*
|
|
*
|
|
Company D
|
26
|
|
13
|
|
22
|
|
Company E
|
*
|
|
*
|
|
21
|
|
Company F
|
*
|
|
*
|
|
*
|
|
U.S Government funded Research and Development Contracts
|
4
|
|
7
|
|
10
|
|
|
Fiscal Year
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Current
|
|
|
|
|
|
||||||
|
Federal
|
$
|
—
|
|
|
$
|
(13,124,000
|
)
|
|
$
|
—
|
|
|
State
|
50,000
|
|
|
12,000
|
|
|
64,000
|
|
|||
|
Foreign
|
—
|
|
|
(34,000
|
)
|
|
—
|
|
|||
|
Total current provision (benefit)
|
50,000
|
|
|
(13,146,000
|
)
|
|
64,000
|
|
|||
|
Deferred
|
|
|
|
|
|
||||||
|
Federal
|
(9,554,000
|
)
|
|
(3,616,000
|
)
|
|
(2,878,000
|
)
|
|||
|
State
|
(1,709,000
|
)
|
|
644,000
|
|
|
(505,000
|
)
|
|||
|
Foreign
|
411,000
|
|
|
(565,000
|
)
|
|
73,000
|
|
|||
|
Change in valuation allowance
|
10,622,000
|
|
|
3,750,000
|
|
|
4,345,000
|
|
|||
|
Total deferred (benefit) provision
|
(230,000
|
)
|
|
213,000
|
|
|
1,035,000
|
|
|||
|
Total (benefit) provision for income taxes
|
$
|
(180,000
|
)
|
|
$
|
(12,933,000
|
)
|
|
$
|
1,099,000
|
|
|
|
Fiscal Year
|
||||||||||
|
|
2014
|
|
2013
|
|
2012
|
||||||
|
Tax provision at federal statutory rates
|
$
|
(9,964,000
|
)
|
|
$
|
(13,322,000
|
)
|
|
$
|
(7,002,000
|
)
|
|
State tax liability
|
33,000
|
|
|
8,000
|
|
|
42,000
|
|
|||
|
Foreign deferred
|
371,000
|
|
|
(644,000
|
)
|
|
734,000
|
|
|||
|
Foreign withholding
|
(196,000
|
)
|
|
308,000
|
|
|
1,170,000
|
|
|||
|
Outside basis in KTC and Kowon, net
|
(394,000
|
)
|
|
(202,000
|
)
|
|
2,422,000
|
|
|||
|
Goodwill
|
—
|
|
|
—
|
|
|
417,000
|
|
|||
|
Nondeductible expenses
|
(21,000
|
)
|
|
306,000
|
|
|
(18,000
|
)
|
|||
|
Increase in net state operating loss carryforwards
|
(177,000
|
)
|
|
(2,868,000
|
)
|
|
—
|
|
|||
|
Utilization of net operating losses for U.K. research and development refund
|
1,089,000
|
|
|
—
|
|
|
—
|
|
|||
|
Provision to tax return adjustments and state tax rate change
|
(516,000
|
)
|
|
(33,000
|
)
|
|
(462,000
|
)
|
|||
|
Tax credits
|
(610,000
|
)
|
|
(390,000
|
)
|
|
(100,000
|
)
|
|||
|
Non-deductible 162M compensation limitations
|
196,000
|
|
|
558,000
|
|
|
198,000
|
|
|||
|
Non-deductible equity compensation
|
(687,000
|
)
|
|
(418,000
|
)
|
|
136,000
|
|
|||
|
Other, net
|
74,000
|
|
|
14,000
|
|
|
(783,000
|
)
|
|||
|
Change in valuation allowance
|
10,622,000
|
|
|
3,750,000
|
|
|
4,345,000
|
|
|||
|
|
$
|
(180,000
|
)
|
|
$
|
(12,933,000
|
)
|
|
$
|
1,099,000
|
|
|
|
Fiscal Year
|
||||||
|
|
2014
|
|
2013
|
||||
|
Deferred tax liability:
|
|
|
|
||||
|
Intangible asset
|
$
|
—
|
|
|
$
|
(141,000
|
)
|
|
Foreign withholding liability
|
(1,282,000
|
)
|
|
(1,478,000
|
)
|
||
|
Foreign unremitted earnings
|
(2,882,000
|
)
|
|
(3,276,000
|
)
|
||
|
Deferred tax assets:
|
|
|
|
||||
|
Federal net operating loss carryforwards
|
22,758,000
|
|
|
15,322,000
|
|
||
|
State net operating loss carryforwards
|
1,689,000
|
|
|
624,000
|
|
||
|
Foreign net operating loss carryforwards
|
2,612,000
|
|
|
3,202,000
|
|
||
|
Equity awards
|
2,508,000
|
|
|
1,666,000
|
|
||
|
Tax credits
|
6,267,000
|
|
|
5,657,000
|
|
||
|
Equipment
|
1,024,000
|
|
|
838,000
|
|
||
|
Investments
|
5,279,000
|
|
|
4,594,000
|
|
||
|
Other
|
3,253,000
|
|
|
3,365,000
|
|
||
|
Net deferred tax assets
|
41,226,000
|
|
|
30,373,000
|
|
||
|
Valuation allowance
|
(42,508,000
|
)
|
|
(31,886,000
|
)
|
||
|
|
$
|
(1,282,000
|
)
|
|
$
|
(1,513,000
|
)
|
|
|
Fiscal Year Ended
|
||||||
|
|
December 27,
2014 |
|
December 28,
2013 |
||||
|
Beginning Balance
|
$
|
716,000
|
|
|
$
|
716,000
|
|
|
Additions
|
389,000
|
|
|
798,000
|
|
||
|
Claim and reversals
|
(389,000
|
)
|
|
(798,000
|
)
|
||
|
Ending Balance
|
$
|
716,000
|
|
|
$
|
716,000
|
|
|
Fiscal Year ending,
|
Amount
|
||
|
2015
|
$
|
1,239,000
|
|
|
2016
|
908,000
|
|
|
|
2017
|
665,000
|
|
|
|
2018
|
641,000
|
|
|
|
2019
|
638,000
|
|
|
|
Thereafter
|
2,130,000
|
|
|
|
Total minimum lease payments
|
$
|
6,221,000
|
|
|
|
Kopin
|
|
FDD
|
|
Total
|
||||||
|
2014
|
|
|
|
|
|
||||||
|
Revenues
|
$
|
28,333
|
|
|
$
|
3,474
|
|
|
$
|
31,807
|
|
|
Net loss attributable to the controlling interest
|
(26,402
|
)
|
|
(1,810
|
)
|
|
(28,212
|
)
|
|||
|
Total assets from continuing operations
|
121,301
|
|
|
1,640
|
|
|
122,941
|
|
|||
|
Long-lived assets from continuing operations
|
4,343
|
|
|
246
|
|
|
4,589
|
|
|||
|
2013
|
|
|
|
|
|
||||||
|
Revenues
|
$
|
19,883
|
|
|
$
|
3,014
|
|
|
$
|
22,898
|
|
|
Net loss attributable to the controlling interest
|
(2,003
|
)
|
|
(2,707
|
)
|
|
(4,710
|
)
|
|||
|
Total assets from continuing operations
|
143,953
|
|
|
2,179
|
|
|
146,132
|
|
|||
|
Long-lived assets from continuing operations
|
5,488
|
|
|
547
|
|
|
6,035
|
|
|||
|
2012
|
|
|
|
|
|
||||||
|
Revenues
|
$
|
31,879
|
|
|
$
|
2,763
|
|
|
$
|
34,642
|
|
|
Net loss attributable to the controlling interest
|
(17,067
|
)
|
|
(4,083
|
)
|
|
(21,150
|
)
|
|||
|
Total assets from continuing operations
|
134,375
|
|
|
4,202
|
|
|
138,577
|
|
|||
|
Long-lived assets from continuing operations
|
7,728
|
|
|
758
|
|
|
8,486
|
|
|||
|
|
Fiscal Year
|
|||||||||||||||||||
|
|
2014
|
|
2013
|
|
2012
|
|||||||||||||||
|
|
Revenue
|
|
% of Total
|
|
Revenue
|
|
% of Total
|
|
Revenue
|
|
% of Total
|
|||||||||
|
US
|
$
|
19,695,000
|
|
|
62
|
%
|
|
$
|
11,927,000
|
|
|
53
|
%
|
|
$
|
25,356,000
|
|
|
73
|
%
|
|
Other Americas
|
416,000
|
|
|
1
|
%
|
|
230,000
|
|
|
1
|
%
|
|
93,000
|
|
|
—
|
%
|
|||
|
Total Americas
|
20,111,000
|
|
|
63
|
%
|
|
12,157,000
|
|
|
54
|
%
|
|
25,449,000
|
|
|
73
|
%
|
|||
|
Asia-Pacific
|
8,245,000
|
|
|
26
|
%
|
|
8,292,000
|
|
|
36
|
%
|
|
7,132,000
|
|
|
21
|
%
|
|||
|
Europe
|
3,451,000
|
|
|
11
|
%
|
|
2,449,000
|
|
|
10
|
%
|
|
2,061,000
|
|
|
6
|
%
|
|||
|
Total Revenues
|
31,807,000
|
|
|
100
|
%
|
|
$
|
22,898,000
|
|
|
100
|
%
|
|
$
|
34,642,000
|
|
|
100
|
%
|
|
|
|
Fiscal Years
|
||||||
|
|
2014
|
|
2013
|
||||
|
United States of America
|
$
|
2,689,000
|
|
|
$
|
3,050,000
|
|
|
United Kingdom
|
377,000
|
|
|
795,000
|
|
||
|
Republic of Korea
|
1,523,000
|
|
|
2,190,000
|
|
||
|
|
$
|
4,589,000
|
|
|
$
|
6,035,000
|
|
|
|
Three months ended March 29, 2014
|
|
Three months
ended June 28, 2014 (3) |
|
Three months ended September 27, 2014
|
|
Three months
ended December 27, 2014 |
||||||||
|
|
(In thousands, except per share data)
|
||||||||||||||
|
Revenue
|
$
|
4,695
|
|
|
$
|
6,943
|
|
|
$
|
9,532
|
|
|
$
|
10,637
|
|
|
Gross profit (2)
|
$
|
2
|
|
|
$
|
753
|
|
|
$
|
3,861
|
|
|
$
|
2,701
|
|
|
Loss from operations
|
$
|
(9,614
|
)
|
|
$
|
(7,269
|
)
|
|
$
|
(5,520
|
)
|
|
$
|
(6,073
|
)
|
|
Net loss attributable to the controlling interest
|
$
|
(9,134
|
)
|
|
$
|
(8,806
|
)
|
|
$
|
(4,469
|
)
|
|
$
|
(5,302
|
)
|
|
Net loss per share from continuing operations (1):
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
(0.15
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.08
|
)
|
|
Diluted
|
$
|
(0.15
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.08
|
)
|
|
$
|
(0.08
|
)
|
|
Shares used in computing net loss per share from continuing operations:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
62,530
|
|
|
62,644
|
|
|
62,647
|
|
|
62,734
|
|
||||
|
Diluted
|
62,530
|
|
|
62,644
|
|
|
62,647
|
|
|
62,734
|
|
||||
|
(1)
|
Net loss per share is computed independently for each of the quarters presented; accordingly, the sum of the quarterly net income per share may not equal the total computed for the year.
|
|
(2)
|
Gross profit is defined as net product revenue less cost of product revenues.
|
|
(3)
|
Includes
$1.3 million
impact in loss from operations and net loss attributable to the controlling interest attributable to the write off of an investment for the three month period ended
June 28, 2014
, as described in Note 4.
|
|
|
Three months ended March 30, 2013
|
|
Three months ended June 29, 2013
|
|
Three months ended September 28, 2013
|
|
Three months
ended December 28, 2013 (3) |
||||||||
|
|
(In thousands, except per share data)
|
||||||||||||||
|
Revenue
|
$
|
6,319
|
|
|
$
|
6,079
|
|
|
$
|
4,950
|
|
|
$
|
5,550
|
|
|
Gross profit (2)
|
$
|
(396
|
)
|
|
$
|
(595
|
)
|
|
$
|
267
|
|
|
$
|
645
|
|
|
(Loss) income from continuing operations
|
$
|
1,168
|
|
|
$
|
(8,062
|
)
|
|
$
|
(9,015
|
)
|
|
$
|
(9,844
|
)
|
|
Net loss attributable to the controlling interest
|
$
|
21,634
|
|
|
$
|
(7,910
|
)
|
|
$
|
(8,771
|
)
|
|
$
|
(9,660
|
)
|
|
Net loss per share from continuing operations (1):
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.34
|
|
|
$
|
(0.13
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.16
|
)
|
|
Diluted
|
$
|
0.34
|
|
|
$
|
(0.13
|
)
|
|
$
|
(0.14
|
)
|
|
$
|
(0.16
|
)
|
|
Shares used in computing net loss per share from continuing operations:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
63,936
|
|
|
62,492
|
|
|
63,542
|
|
|
61,529
|
|
||||
|
Diluted
|
63,936
|
|
|
62,492
|
|
|
63,542
|
|
|
61,529
|
|
||||
|
(1)
|
Net loss per share is computed independently for each of the quarters presented; accordingly, the sum of the quarterly net income per share may not equal the total computed for the year.
|
|
(2)
|
Gross profit is defined as net component revenue less cost of component revenues.
|
|
(3)
|
Includes
$4.0 million
impact in loss from continuing operations and net loss attributable to the controlling interest attributable to the impairment of intangibles and write off of investments for the three month period ended
December 28, 2013
, as described in Notes 4 and 6.
|
|
|
K
OPIN
C
ORPORATION
|
|
|
|
|
|
|
|
By:
|
/s/ J
OHN
C.C. F
AN
|
|
|
|
John C.C. Fan
Chairman of the Board, Chief Executive Officer, President and Director
|
|
Signature
|
|
Title
|
|
Date
|
|
|
|
|
|
|
|
/s/ J
OHN
C.C. F
AN
|
|
Chairman of the Board, Chief Executive Officer, President and Director (Principal Executive Officer)
|
|
March 12, 2015
|
|
John C.C. Fan
|
|
|
|
|
|
|
|
|
|
|
|
/s/ J
AMES
B
REWINGTON
|
|
Director
|
|
March 12, 2015
|
|
James Brewington
|
|
|
|
|
|
|
|
|
|
|
|
/s/ D
AVID
E. B
ROOK
|
|
Director
|
|
March 12, 2015
|
|
David E. Brook
|
|
|
|
|
|
|
|
|
|
|
|
/s/ M
ORTON
C
OLLINS
|
|
Director
|
|
March 12, 2015
|
|
Morton Collins
|
|
|
|
|
|
|
|
|
|
|
|
/s/ A
NDREW
H. C
HAPMAN
|
|
Director
|
|
March 12, 2015
|
|
Andrew H. Chapman
|
|
|
|
|
|
|
|
|
|
|
|
/s/ CHI CHIA HSIEH
|
|
Director
|
|
March 12, 2015
|
|
Chi Chia Hsieh
|
|
|
|
|
|
|
|
|
|
|
|
/s/ M
ICHAEL
J. L
ANDINE
|
|
Director
|
|
March 12, 2015
|
|
Michael J. Landine
|
|
|
|
|
|
|
|
|
|
|
|
/s/ R
ICHARD
A. S
NEIDER
|
|
Treasurer and Chief Financial Officer (Principal Financial and Accounting Officer)
|
|
March 12, 2015
|
|
Richard A. Sneider
|
|
|
|
|
|
Description
|
Balance at
Beginning
of Year
|
|
Additions
Charged
to
Income
|
|
Deductions
from
Reserve
|
|
Balance at
End of
Year
|
||||||||
|
Reserve deducted from assets—allowance for doubtful accounts:
|
|
|
|
|
|
|
|
||||||||
|
2012
|
$
|
513,000
|
|
|
$
|
139,000
|
|
|
$
|
(341,000
|
)
|
|
$
|
311,000
|
|
|
2013
|
311,000
|
|
|
19,000
|
|
|
(128,000
|
)
|
|
202,000
|
|
||||
|
2014
|
202,000
|
|
|
81,000
|
|
|
(17,000
|
)
|
|
266,000
|
|
||||
|
Exhibits
|
|
|
|
Sequential
page number
|
|
|
|
3.1
|
|
|
Amended and Restated Certificate of Incorporation
|
(2
|
)
|
|
|
3.2
|
|
|
Amendment to Certificate of Incorporation
|
(5
|
)
|
|
|
3.3
|
|
|
Amendment to Certificate of Incorporation
|
(5
|
)
|
|
|
3.4
|
|
|
Fourth Amended and Restated By-laws
|
(8
|
)
|
|
|
4
|
|
|
Specimen Certificate of Common Stock
|
(1
|
)
|
|
|
10.1
|
|
|
Form of Employee Agreement with Respect to Inventions and Proprietary Information
|
(1
|
)
|
|
|
10.2
|
|
|
Kopin Corporation 2001 Equity Incentive Plan
|
(7
|
)
|
*
|
|
10.3
|
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(9
|
)
|
*
|
|
10.4
|
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(10
|
)
|
*
|
|
10.5
|
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(11
|
)
|
*
|
|
10.6
|
|
|
Kopin Corporation 2001 Equity Incentive Plan Amendment
|
(13
|
)
|
*
|
|
10.7
|
|
|
Kopin Corporation 2001 Supplemental Equity Incentive Plan
|
(6
|
)
|
*
|
|
10.8
|
|
|
Form of Key Employee Stock Purchase Agreement
|
(1
|
)
|
*
|
|
10.9
|
|
|
License Agreement by and between the Company and Massachusetts Institute of Technology dated April 22, 1985, as amended
|
(1
|
)
|
|
|
10.10
|
|
|
Facility Lease, by and between the Company and Massachusetts Technology Park Corporation, dated October 15, 1993
|
(3
|
)
|
|
|
10.11
|
|
|
Joint Venture Agreement, by and among the Company, Kowon Technology Co., Ltd., and Korean Investors, dated as of March 3, 1998
|
(4
|
)
|
|
|
10.12
|
|
|
Eighth Amended and Restated Employment Agreement between the Company and Dr. John C.C. Fan, dated as of December 31, 2014
|
*
|
|
|
|
10.13
|
|
|
Kopin Corporation Form of Stock Option Agreement under 2001 and 2010 Equity Incentive Plans
|
(12
|
)
|
*
|
|
10.14
|
|
|
Kopin Corporation 2001 and 2010 Equity Incentive Plan Form of Restricted Stock Purchase Agreement
|
(12
|
)
|
*
|
|
10.15
|
|
|
Kopin Corporation Fiscal Year 2012 Incentive Bonus Plan
|
*
|
|
|
|
10.16
|
|
|
Kopin Corporation 2010 Equity Incentive Plan
|
(14
|
)
|
|
|
10.17
|
|
|
Purchase Agreement, dated January 10, 2013, by and among Kopin Corporation, IQE KC, LLC and IQE plc
|
(15
|
)
|
|
|
21.1
|
|
|
Subsidiaries of Kopin Corporation
|
|
|
|
|
23.1
|
|
|
Consent of Independent Registered Public Accounting Firm
|
|
|
|
|
31.1
|
|
|
Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
31.2
|
|
|
Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
32.1
|
|
|
Chief Executive Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
32.2
|
|
|
Chief Financial Officer Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
|
|
|
|
|
101.0
|
|
|
The following materials from the Company’s Annual Report on Form 10-K for the fiscal year ended December 27, 2014, formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Balance Sheets, (ii) Consolidated Statements of Operations, (iii) Consolidated Statements of Comprehensive Loss, (iv) Consolidated Statements of Stockholder's Equity, (v) Consolidated Statements of Cash Flows, and (vi) Notes to Consolidated Financial Statements, tagged as blocks of text
|
|
|
|
|
*
|
|
|
Management contract or compensatory plan required to be filed as an Exhibit to this Annual Report on Form 10-K.
|
|
**
|
|
|
This exhibit shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof and irrespective of any general incorporation language in any filing.
|
|
(1
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-1, File No. 33-45853, and incorporated herein by reference.
|
|
(2
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-1, File No. 33-57450, and incorporated herein by reference.
|
|
(3
|
)
|
|
Filed as an exhibit to Annual Report on Form 10-K for the fiscal year ended December 31, 1993 and incorporated herein by reference.
|
|
(4
|
)
|
|
Filed as an exhibit to Annual Report on Form 10-Q for the quarterly period ended June 27, 1998 and incorporated herein by reference.
|
|
(5
|
)
|
|
Filed as an exhibit to Quarterly Report on Form 10-Q for the quarterly period ended July 1, 2000 and incorporated herein by reference.
|
|
(6
|
)
|
|
Filed as an exhibit to Quarterly Report on Form 10-Q for the quarterly period ended July 1, 2000 and incorporated herein by reference.
|
|
(7
|
)
|
|
Filed as an appendix to Proxy Statement filed on April 20, 2001 and incorporated herein by reference.
|
|
(8
|
)
|
|
Filed as an exhibit to Current Report on Form 8-K filed on December 12, 2008 and incorporated herein by reference.
|
|
(9
|
)
|
|
Filed as an exhibit to Current Report on Form 8-K filed on December 12, 2008 and incorporated herein by reference.
|
|
(10
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8 filed on March 15, 2004 and incorporated herein by reference.
|
|
(11
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8 filed on May 10, 2004 and incorporated herein by reference.
|
|
(12
|
)
|
|
Filed as an exhibit to Annual Report on Form 10-K for the fiscal year ended December 25, 2004 and incorporated herein by reference.
|
|
(13
|
)
|
|
Filed as an exhibit to Registration Statement on Form S-8 filed on April 15, 2008 and incorporated herein by reference.
|
|
(14
|
)
|
|
Filed with the Company's Definitive Proxy Statement on Schedule 14 filed as of April 5, 2013 and incorporated by reference herein.
|
|
(15
|
)
|
|
Filed as an exhibit to Current Report on Form 8-K on January 10, 2013 and incorporated by reference herein.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|